Chugai Pharmaceutical Co., Ltd. v. Alexion Pharmaceuticals, Inc.
1:18-cv-01802
Overview
Parties
Defendant
Alexion Pharmaceuticals, Inc. Operating Company
Represented By
10 Attorneys ListedFarnan LLP
919 North Market Street, 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
Plaintiff
Chugai Pharmaceutical Co., Ltd. Operating Company
Represented By
11 Attorneys ListedShaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Shaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 7 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 9,890,377 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇯🇵 Japan | JP 2008104147 | Japan Counterpart | View Official Patent → |
| 🇯🇵 Japan | JP 2008247713 | Japan Counterpart | View Official Patent → |
| 🇯🇵 Japan | JP 2009068744 | Japan Counterpart | View Official Patent → |
| 🌐 PCT International (WIPO) | WO 2009125825 A1 | PCT World Application | View Official Patent → |
| 🇺🇸 United States | US 93,658,711 A | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2013001186 | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US9890377
Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
|
Filed: 2013-05-08
Issued: 2018-02-13
|
Active (3.0 yrs remaining)
Expires: 2029-11-02
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
24
Dispositive
0
Granted
0
Denied
0
Pending / Review
24
Motions by Category
Key Dispositive Motions & Rulings